Skip to Main Content

Paper Details

Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.
JAMA Netw Open
10
2021
Author NameAffiliation
Celestia S HiganoFred Hutchinson Cancer Research Center, University of Washington
Alan H BryceGenomic Oncology Clinic, Mayo Clinic
  • 1 - 2

Datasets